Published in Support Care Cancer on August 06, 2008
Why do patients agree to a "Do not resuscitate" or "Full code" order? Perspectives of medical inpatients. J Gen Intern Med (2011) 1.07
Relationship between cancer patients' predictions of prognosis and their treatment preferences. JAMA (1998) 12.60
Survival after cardiopulmonary resuscitation in the hospital. N Engl J Med (1983) 8.07
Prognostic disclosure to patients with cancer near the end of life. Ann Intern Med (2001) 5.19
Orders not to resuscitate. N Engl J Med (1976) 2.87
Communication and decision-making in seriously ill patients: findings of the SUPPORT project. The Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. J Am Geriatr Soc (2000) 2.12
Approaching the end of life: attitudes, preferences, and behaviors of African-American and white patients and their family caregivers. J Clin Oncol (2003) 1.97
Guidelines for the appropriate use of do-not-resuscitate orders. Council on Ethical and Judicial Affairs, American Medical Association. JAMA (1991) 1.75
Outcome of cardiopulmonary resuscitation in the intensive care setting. Arch Intern Med (1992) 1.47
Characteristics of cardiac arrest in cancer patients as a predictor of survival after cardiopulmonary resuscitation. Cancer (2001) 1.17
Cardiopulmonary resuscitation and the patient with cancer. J Clin Oncol (1991) 1.12
Contracts, covenants and advance care planning: an empirical study of the moral obligations of patient and proxy. J Pain Symptom Manage (2005) 1.07
Outcome and cost implications of cardiopulmonary resuscitation in the medical intensive care unit of a comprehensive cancer center. Support Care Cancer (2002) 0.83
Prognostic factors in cardiac arrest occurring in a district general hospital. Br J Clin Pract (1986) 0.78
Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. J Clin Oncol (2013) 5.07
Availability and integration of palliative care at US cancer centers. JAMA (2010) 4.51
Supportive versus palliative care: what's in a name?: a survey of medical oncologists and midlevel providers at a comprehensive cancer center. Cancer (2009) 2.58
Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study. J Clin Oncol (2003) 2.38
Treatment decisions for breast carcinoma: patient preferences and physician perceptions. Cancer (2002) 1.98
Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients. J Hepatol (2012) 1.93
Parenteral hydration in patients with advanced cancer: a multicenter, double-blind, placebo-controlled randomized trial. J Clin Oncol (2012) 1.86
Interval between first palliative care consult and death in patients diagnosed with advanced cancer at a comprehensive cancer center. J Palliat Med (2008) 1.76
A randomized controlled trial of celecoxib to prevent recurrence of nonmuscle-invasive bladder cancer. Cancer Prev Res (Phila) (2011) 1.70
Interval between palliative care referral and death among patients treated at a comprehensive cancer center. J Palliat Med (2005) 1.67
Study of the media's potential influence on prospective research participants' understanding of and motivations for participation in a high-profile phase I trial. J Clin Oncol (2002) 1.64
Phosphorylation of human p53 at serine 46 determines promoter selection and whether apoptosis is attenuated or amplified. J Biol Chem (2005) 1.62
Manipulation of base excision repair to sensitize ovarian cancer cells to alkylating agent temozolomide. Clin Cancer Res (2007) 1.60
The effect of oral methadone on the QTc interval in advanced cancer patients: a prospective pilot study. J Palliat Med (2010) 1.57
Palliative care inpatient service in a comprehensive cancer center: clinical and financial outcomes. J Clin Oncol (2004) 1.55
Inpatient rehabilitation improved functional status in asthenic patients with solid and hematologic malignancies. Am J Phys Med Rehabil (2011) 1.54
Nebulized versus subcutaneous morphine for patients with cancer dyspnea: a preliminary study. J Pain Symptom Manage (2005) 1.52
An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies. J Clin Oncol (2004) 1.52
Advance care planning: Beyond the living will. Cleve Clin J Med (2009) 1.51
Methylphenidate and/or a nursing telephone intervention for fatigue in patients with advanced cancer: a randomized, placebo-controlled, phase II trial. J Clin Oncol (2013) 1.48
Selenomethionine regulation of p53 by a ref1-dependent redox mechanism. Proc Natl Acad Sci U S A (2002) 1.45
Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol (2006) 1.45
Place of death of Houston area residents with cancer over a two-year period. J Pain Symptom Manage (2003) 1.44
The newly and nearly dead. Hastings Cent Rep (2003) 1.38
Place of death and its predictors for local patients registered at a comprehensive cancer center. J Clin Oncol (2002) 1.34
Characteristics, findings, and outcomes of palliative care inpatient consultations at a comprehensive cancer center. J Palliat Med (2007) 1.32
Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study. J Clin Oncol (2004) 1.32
Systematic review of acupuncture in cancer care: a synthesis of the evidence. J Clin Oncol (2013) 1.30
Symptomatic hypogonadism in male survivors of cancer with chronic exposure to opioids. Cancer (2004) 1.25
Potent analgesics are more expensive for patients in developing countries: a comparative study. J Pain Palliat Care Pharmacother (2004) 1.22
Donepezil for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol (2007) 1.20
Impact of delirium and recall on the level of distress in patients with advanced cancer and their family caregivers. Cancer (2009) 1.20
Antineoplastic therapy use in patients with advanced cancer admitted to an acute palliative care unit at a comprehensive cancer center: a simultaneous care model. Cancer (2010) 1.19
Characteristics and correlates of dyspnea in patients with advanced cancer. J Palliat Med (2009) 1.18
Understanding the role of physician assistants in oncology. J Oncol Pract (2009) 1.18
Hepatic stem cells and transforming growth factor β in hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol (2012) 1.17
Imbalancing the DNA base excision repair pathway in the mitochondria; targeting and overexpressing N-methylpurine DNA glycosylase in mitochondria leads to enhanced cell killing. Cancer Res (2003) 1.17
Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report. J Clin Oncol (2003) 1.16
Alcoholism screening in patients with advanced cancer: impact on symptom burden and opioid use. J Palliat Med (2008) 1.15
Predictors of access to palliative care services among patients who died at a Comprehensive Cancer Center. J Palliat Med (2007) 1.14
Implication of p53 in base excision DNA repair: in vivo evidence. Oncogene (2002) 1.14
A randomized, controlled trial of physician postures when breaking bad news to cancer patients. Palliat Med (2007) 1.12
Treatment with sunitinib for patients with progressive metastatic pheochromocytomas and sympathetic paragangliomas. J Clin Endocrinol Metab (2012) 1.11
The impact of palliative care consultation on symptom assessment, communication needs, and palliative interventions in pediatric patients with cancer. J Palliat Med (2009) 1.09
National practices regarding payment to research subjects for participating in pediatric research. Pediatrics (2002) 1.09
Vascular ligand-receptor mapping by direct combinatorial selection in cancer patients. Proc Natl Acad Sci U S A (2011) 1.09
Bone metastases and skeletal-related events in patients with malignant pheochromocytoma and sympathetic paraganglioma. J Clin Endocrinol Metab (2013) 1.08
Improving wait time for chemotherapy in an outpatient clinic at a comprehensive cancer center. J Oncol Pract (2012) 1.08
Undocumented alcoholism and its correlation with tobacco and illegal drug use in advanced cancer patients. Cancer (2011) 1.07
The Edmonton Symptom Assessment System as a screening tool for depression and anxiety. J Palliat Med (2006) 1.06
Symptom distress in advanced cancer patients with anxiety and depression in the palliative care setting. Support Care Cancer (2008) 1.06
Selenomethionine induction of DNA repair response in human fibroblasts. Oncogene (2002) 1.03
Chemotherapeutic selectivity conferred by selenium: a role for p53-dependent DNA repair. Mol Cancer Ther (2007) 1.02
Impact of a half-day multidisciplinary symptom control and palliative care outpatient clinic in a comprehensive cancer center on recommendations, symptom intensity, and patient satisfaction: a retrospective descriptive study. J Pain Symptom Manage (2004) 1.02
The role of thalidomide and placebo for the treatment of cancer-related anorexia-cachexia symptoms: results of a double-blind placebo-controlled randomized study. J Palliat Med (2012) 1.02
Integrative medicine consultation service in a comprehensive cancer center: findings and outcomes. Integr Cancer Ther (2010) 1.02
Electro-acupuncture to prevent prolonged postoperative ileus: a randomized clinical trial. World J Gastroenterol (2010) 1.00
The impact of hypogonadism and autonomic dysfunction on fatigue, emotional function, and sexual desire in male patients with advanced cancer: a pilot study. Cancer (2006) 1.00
Direct correlation between FRA3B expression and cigarette smoking. Genes Chromosomes Cancer (2002) 0.99
Revisiting ethical guidelines for research with terminal wean and brain-dead participants. Hastings Cent Rep (2003) 0.99
Prospective assessment of the reliability, validity, and sensitivity to change of the Functional Assessment of Cancer Therapy-Melanoma questionnaire. Cancer (2008) 0.98
Selenium protection from DNA damage involves a Ref1/p53/Brca1 protein complex. Anticancer Res (2006) 0.98
Association between fatigue and other cancer-related symptoms in patients with advanced cancer. Support Care Cancer (2008) 0.97
Effects of parenteral hydration in terminally ill cancer patients: a preliminary study. J Clin Oncol (2005) 0.97
Dexamethasone in addition to metoclopramide for chronic nausea in patients with advanced cancer: a randomized controlled trial. J Pain Symptom Manage (2004) 0.96
Breast cancer patient perception of the helpfulness of a prompt sheet versus a general information sheet during outpatient consultation: a randomized, controlled trial. J Pain Symptom Manage (2003) 0.96
Impact of a palliative care service on in-hospital mortality in a comprehensive cancer center. J Palliat Med (2006) 0.95
Acupuncture for radiation-induced xerostomia in patients with cancer: a pilot study. Head Neck (2009) 0.95
The association between autonomic dysfunction and survival in male patients with advanced cancer: a preliminary report. J Pain Symptom Manage (2010) 0.94
Protection by dendritic cells-based HIV synthetic peptide cocktail vaccine: preclinical studies in the SHIV-rhesus model. Vaccine (2005) 0.94
A randomized controlled trial of supplemental oxygen versus air in cancer patients with dyspnea. Palliat Med (2003) 0.93
Mapping FACT-melanoma quality-of-life scores to EQ-5D health utility weights. Value Health (2011) 0.93
A systematic review of activities at a high-volume ethics consultation service. J Clin Ethics (2011) 0.92
Association between self-reported sleep disturbance and other symptoms in patients with advanced cancer. J Pain Symptom Manage (2011) 0.92
Utilization of and Attitudes towards Traditional Chinese Medicine Therapies in a Chinese Cancer Hospital: A Survey of Patients and Physicians. Evid Based Complement Alternat Med (2012) 0.92
Phase I participants' views of quality of life and trial participation burdens. Support Care Cancer (2007) 0.92
Hypogonadism and sexual dysfunction in male cancer survivors receiving chronic opioid therapy. J Pain Symptom Manage (2003) 0.92
Randomized controlled trial of acupuncture for prevention of radiation-induced xerostomia among patients with nasopharyngeal carcinoma. Cancer (2011) 0.92
Prevalence of symptom control and palliative care abstracts presented at the Annual Meeting of the American Society for Therapeutic Radiology and Oncology. Int J Radiat Oncol Biol Phys (2002) 0.91
Practical guidance for charting ethics consultations. HEC Forum (2014) 0.90
Advance directives and do-not-resuscitate orders in patients with cancer with metastatic spinal cord compression: advanced care planning implications. J Palliat Med (2010) 0.90
Single- vs. multiple-item instruments in the assessment of quality of life in patients with advanced cancer. J Pain Symptom Manage (2010) 0.90
Intermittent subcutaneous opioids for the management of cancer pain. J Palliat Med (2008) 0.90
Associations among hypogonadism, C-reactive protein, symptom burden, and survival in male cancer patients with cachexia: a preliminary report. J Pain Symptom Manage (2010) 0.90
Assessment of palliative care cancer patients' most important concerns. Support Care Cancer (2010) 0.89